IMBARKYD
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Jul 2024)
What this means for you
This application is over — abandoned 22 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90544448
- Mark type
- Stylized text
- Filed
- 24 Feb 2021
- Published for opposition
- 26 Oct 2021
- Abandoned
- 22 Jul 2024
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of renal, cardiovascular, and metabolic diseases and disorders including diabetes
Owner
- Reata Pharmaceuticals Inc., Irving, TX, US
- Reata Pharmaceuticals Inc., Irving, TX, US
Prosecution history
- 22 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2023 — SOU EXTENSION 4 GRANTED
- 06 Dec 2023 — SOU EXTENSION 4 FILED
- 06 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 15 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2023 — SOU EXTENSION 3 GRANTED
- 13 Jun 2023 — SOU EXTENSION 3 FILED
- 13 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 24 May 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 08 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2022 — SOU EXTENSION 2 GRANTED
- 06 Dec 2022 — SOU EXTENSION 2 FILED
- 06 Dec 2022 — SOU TEAS EXTENSION RECEIVED